FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use
Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:FGFR2-TACC2

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: FGFR2-TACC2
FusionPDB ID: 30296
FusionGDB2.0 ID: 30296
HgeneTgene
Gene symbol

FGFR2

TACC2

Gene ID

2263

10579

Gene namefibroblast growth factor receptor 2transforming acidic coiled-coil containing protein 2
SynonymsBBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25AZU-1|ECTACC
Cytomap

10q26.13

10q26.13

Type of geneprotein-codingprotein-coding
Descriptionfibroblast growth factor receptor 2BEK fibroblast growth factor receptorbacteria-expressed kinasekeratinocyte growth factor receptorprotein tyrosine kinase, receptor like 14transforming acidic coiled-coil-containing protein 2anti zuai-1
Modification date2020032220200313
UniProtAcc

P21802

Main function of 5'-partner protein: FUNCTION: Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and immature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1. {ECO:0000269|PubMed:12529371, ECO:0000269|PubMed:15190072, ECO:0000269|PubMed:15629145, ECO:0000269|PubMed:16384934, ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:17311277, ECO:0000269|PubMed:17623664, ECO:0000269|PubMed:18374639, ECO:0000269|PubMed:19103595, ECO:0000269|PubMed:19387476, ECO:0000269|PubMed:19410646, ECO:0000269|PubMed:21596750, ECO:0000269|PubMed:8663044}.		.
Ensembl transtripts involved in fusion geneENST idsENST00000346997, ENST00000351936, 
ENST00000356226, ENST00000357555, 
ENST00000358487, ENST00000360144, 
ENST00000369056, ENST00000369059, 
ENST00000369060, ENST00000369061, 
ENST00000457416, ENST00000478859, 
ENST00000359354, ENST00000490349, 
ENST00000493951, ENST00000260733, 
ENST00000334433, ENST00000358010, 
ENST00000360561, ENST00000368999, 
ENST00000369000, ENST00000369001, 
ENST00000369004, ENST00000369005, 
ENST00000453444, ENST00000513429, 
ENST00000515273, ENST00000515603, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score24 X 20 X 12=576011 X 16 X 4=704
# samples 3814
** MAII scorelog2(38/5760*10)=-3.92199748799873
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(14/704*10)=-2.33014860169233
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: FGFR2 [Title/Abstract] AND TACC2 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: FGFR2 [Title/Abstract] AND TACC2 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)FGFR2(123243212)-TACC2(123996910), # samples:3
Anticipated loss of major functional domain due to fusion event.FGFR2-TACC2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
FGFR2-TACC2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
FGFR2-TACC2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
FGFR2-TACC2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
FGFR2-TACC2 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF.
FGFR2-TACC2 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
FGFR2-TACC2 seems lost the major protein functional domain in Hgene partner, which is a kinase due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneFGFR2

GO:0008284

positive regulation of cell proliferation

8663044

HgeneFGFR2

GO:0008543

fibroblast growth factor receptor signaling pathway

8663044|15629145

HgeneFGFR2

GO:0018108

peptidyl-tyrosine phosphorylation

15629145|16844695

HgeneFGFR2

GO:0046777

protein autophosphorylation

15629145



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr10:123243212/chr10:123996910)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across FGFR2 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across TACC2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)
ENST00000369061FGFR2chr10123243212-ENST00000369005TACC2chr10123996910+33212115482834928
ENST00000369061FGFR2chr10123243212-ENST00000513429TACC2chr10123996910+33242115482834928
ENST00000369061FGFR2chr10123243212-ENST00000515273TACC2chr10123996910+31242115482834928
ENST00000369061FGFR2chr10123243212-ENST00000515603TACC2chr10123996910+31272115482834928
ENST00000369061FGFR2chr10123243212-ENST00000453444TACC2chr10123996910+31242115482834928
ENST00000369061FGFR2chr10123243212-ENST00000358010TACC2chr10123996910+33192115482834928
ENST00000369061FGFR2chr10123243212-ENST00000334433TACC2chr10123996910+33192115482834928
ENST00000369061FGFR2chr10123243212-ENST00000369001TACC2chr10123996910+33212115482834928
ENST00000369061FGFR2chr10123243212-ENST00000369000TACC2chr10123996910+33232115482834928
ENST00000369061FGFR2chr10123243212-ENST00000360561TACC2chr10123996910+33242115482834928
ENST00000369061FGFR2chr10123243212-ENST00000368999TACC2chr10123996910+32622115482834928
ENST00000369061FGFR2chr10123243212-ENST00000369004TACC2chr10123996910+33242115482834928
ENST00000369061FGFR2chr10123243212-ENST00000260733TACC2chr10123996910+33172115482834928
ENST00000346997FGFR2chr10123243212-ENST00000369005TACC2chr10123996910+351323071230261004
ENST00000346997FGFR2chr10123243212-ENST00000513429TACC2chr10123996910+351623071230261004
ENST00000346997FGFR2chr10123243212-ENST00000515273TACC2chr10123996910+331623071230261004
ENST00000346997FGFR2chr10123243212-ENST00000515603TACC2chr10123996910+331923071230261004
ENST00000346997FGFR2chr10123243212-ENST00000453444TACC2chr10123996910+331623071230261004
ENST00000346997FGFR2chr10123243212-ENST00000358010TACC2chr10123996910+351123071230261004
ENST00000346997FGFR2chr10123243212-ENST00000334433TACC2chr10123996910+351123071230261004
ENST00000346997FGFR2chr10123243212-ENST00000369001TACC2chr10123996910+351323071230261004
ENST00000346997FGFR2chr10123243212-ENST00000369000TACC2chr10123996910+351523071230261004
ENST00000346997FGFR2chr10123243212-ENST00000360561TACC2chr10123996910+351623071230261004
ENST00000346997FGFR2chr10123243212-ENST00000368999TACC2chr10123996910+345423071230261004
ENST00000346997FGFR2chr10123243212-ENST00000369004TACC2chr10123996910+351623071230261004
ENST00000346997FGFR2chr10123243212-ENST00000260733TACC2chr10123996910+350923071230261004
ENST00000369056FGFR2chr10123243212-ENST00000369005TACC2chr10123996910+353423282430471007
ENST00000369056FGFR2chr10123243212-ENST00000513429TACC2chr10123996910+353723282430471007
ENST00000369056FGFR2chr10123243212-ENST00000515273TACC2chr10123996910+333723282430471007
ENST00000369056FGFR2chr10123243212-ENST00000515603TACC2chr10123996910+334023282430471007
ENST00000369056FGFR2chr10123243212-ENST00000453444TACC2chr10123996910+333723282430471007
ENST00000369056FGFR2chr10123243212-ENST00000358010TACC2chr10123996910+353223282430471007
ENST00000369056FGFR2chr10123243212-ENST00000334433TACC2chr10123996910+353223282430471007
ENST00000369056FGFR2chr10123243212-ENST00000369001TACC2chr10123996910+353423282430471007
ENST00000369056FGFR2chr10123243212-ENST00000369000TACC2chr10123996910+353623282430471007
ENST00000369056FGFR2chr10123243212-ENST00000360561TACC2chr10123996910+353723282430471007
ENST00000369056FGFR2chr10123243212-ENST00000368999TACC2chr10123996910+347523282430471007
ENST00000369056FGFR2chr10123243212-ENST00000369004TACC2chr10123996910+353723282430471007
ENST00000369056FGFR2chr10123243212-ENST00000260733TACC2chr10123996910+353023282430471007
ENST00000369061FGFR2chr10123243211-ENST00000369005TACC2chr10123996909+33212115482834928
ENST00000369061FGFR2chr10123243211-ENST00000513429TACC2chr10123996909+33242115482834928
ENST00000369061FGFR2chr10123243211-ENST00000515273TACC2chr10123996909+31242115482834928
ENST00000369061FGFR2chr10123243211-ENST00000515603TACC2chr10123996909+31272115482834928
ENST00000369061FGFR2chr10123243211-ENST00000453444TACC2chr10123996909+31242115482834928
ENST00000369061FGFR2chr10123243211-ENST00000358010TACC2chr10123996909+33192115482834928
ENST00000369061FGFR2chr10123243211-ENST00000334433TACC2chr10123996909+33192115482834928
ENST00000369061FGFR2chr10123243211-ENST00000369001TACC2chr10123996909+33212115482834928
ENST00000369061FGFR2chr10123243211-ENST00000369000TACC2chr10123996909+33232115482834928
ENST00000369061FGFR2chr10123243211-ENST00000360561TACC2chr10123996909+33242115482834928
ENST00000369061FGFR2chr10123243211-ENST00000368999TACC2chr10123996909+32622115482834928
ENST00000369061FGFR2chr10123243211-ENST00000369004TACC2chr10123996909+33242115482834928
ENST00000369061FGFR2chr10123243211-ENST00000260733TACC2chr10123996909+33172115482834928
ENST00000346997FGFR2chr10123243211-ENST00000369005TACC2chr10123996909+351323071230261004
ENST00000346997FGFR2chr10123243211-ENST00000513429TACC2chr10123996909+351623071230261004
ENST00000346997FGFR2chr10123243211-ENST00000515273TACC2chr10123996909+331623071230261004
ENST00000346997FGFR2chr10123243211-ENST00000515603TACC2chr10123996909+331923071230261004
ENST00000346997FGFR2chr10123243211-ENST00000453444TACC2chr10123996909+331623071230261004
ENST00000346997FGFR2chr10123243211-ENST00000358010TACC2chr10123996909+351123071230261004
ENST00000346997FGFR2chr10123243211-ENST00000334433TACC2chr10123996909+351123071230261004
ENST00000346997FGFR2chr10123243211-ENST00000369001TACC2chr10123996909+351323071230261004
ENST00000346997FGFR2chr10123243211-ENST00000369000TACC2chr10123996909+351523071230261004
ENST00000346997FGFR2chr10123243211-ENST00000360561TACC2chr10123996909+351623071230261004
ENST00000346997FGFR2chr10123243211-ENST00000368999TACC2chr10123996909+345423071230261004
ENST00000346997FGFR2chr10123243211-ENST00000369004TACC2chr10123996909+351623071230261004
ENST00000346997FGFR2chr10123243211-ENST00000260733TACC2chr10123996909+350923071230261004
ENST00000369056FGFR2chr10123243211-ENST00000369005TACC2chr10123996909+353423282430471007
ENST00000369056FGFR2chr10123243211-ENST00000513429TACC2chr10123996909+353723282430471007
ENST00000369056FGFR2chr10123243211-ENST00000515273TACC2chr10123996909+333723282430471007
ENST00000369056FGFR2chr10123243211-ENST00000515603TACC2chr10123996909+334023282430471007
ENST00000369056FGFR2chr10123243211-ENST00000453444TACC2chr10123996909+333723282430471007
ENST00000369056FGFR2chr10123243211-ENST00000358010TACC2chr10123996909+353223282430471007
ENST00000369056FGFR2chr10123243211-ENST00000334433TACC2chr10123996909+353223282430471007
ENST00000369056FGFR2chr10123243211-ENST00000369001TACC2chr10123996909+353423282430471007
ENST00000369056FGFR2chr10123243211-ENST00000369000TACC2chr10123996909+353623282430471007
ENST00000369056FGFR2chr10123243211-ENST00000360561TACC2chr10123996909+353723282430471007
ENST00000369056FGFR2chr10123243211-ENST00000368999TACC2chr10123996909+347523282430471007
ENST00000369056FGFR2chr10123243211-ENST00000369004TACC2chr10123996909+353723282430471007
ENST00000369056FGFR2chr10123243211-ENST00000260733TACC2chr10123996909+353023282430471007

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000369061ENST00000369005FGFR2chr10123243212-TACC2chr10123996910+0.0018957520.9981042
ENST00000369061ENST00000513429FGFR2chr10123243212-TACC2chr10123996910+0.0018264590.9981736
ENST00000369061ENST00000515273FGFR2chr10123243212-TACC2chr10123996910+0.0026172630.9973827
ENST00000369061ENST00000515603FGFR2chr10123243212-TACC2chr10123996910+0.002575950.9974241
ENST00000369061ENST00000453444FGFR2chr10123243212-TACC2chr10123996910+0.0026172630.9973827
ENST00000369061ENST00000358010FGFR2chr10123243212-TACC2chr10123996910+0.0019088510.99809116
ENST00000369061ENST00000334433FGFR2chr10123243212-TACC2chr10123996910+0.0019088510.99809116
ENST00000369061ENST00000369001FGFR2chr10123243212-TACC2chr10123996910+0.0018957520.9981042
ENST00000369061ENST00000369000FGFR2chr10123243212-TACC2chr10123996910+0.0018550010.998145
ENST00000369061ENST00000360561FGFR2chr10123243212-TACC2chr10123996910+0.0018264590.9981736
ENST00000369061ENST00000368999FGFR2chr10123243212-TACC2chr10123996910+0.0021426780.9978573
ENST00000369061ENST00000369004FGFR2chr10123243212-TACC2chr10123996910+0.0018264590.9981736
ENST00000369061ENST00000260733FGFR2chr10123243212-TACC2chr10123996910+0.0018964620.9981035
ENST00000346997ENST00000369005FGFR2chr10123243212-TACC2chr10123996910+0.0013218690.99867815
ENST00000346997ENST00000513429FGFR2chr10123243212-TACC2chr10123996910+0.0012731790.9987268
ENST00000346997ENST00000515273FGFR2chr10123243212-TACC2chr10123996910+0.0017400990.99825996
ENST00000346997ENST00000515603FGFR2chr10123243212-TACC2chr10123996910+0.0017227880.9982772
ENST00000346997ENST00000453444FGFR2chr10123243212-TACC2chr10123996910+0.0017400990.99825996
ENST00000346997ENST00000358010FGFR2chr10123243212-TACC2chr10123996910+0.0013270060.99867296
ENST00000346997ENST00000334433FGFR2chr10123243212-TACC2chr10123996910+0.0013270060.99867296
ENST00000346997ENST00000369001FGFR2chr10123243212-TACC2chr10123996910+0.0013218690.99867815
ENST00000346997ENST00000369000FGFR2chr10123243212-TACC2chr10123996910+0.0012924250.99870753
ENST00000346997ENST00000360561FGFR2chr10123243212-TACC2chr10123996910+0.0012731790.9987268
ENST00000346997ENST00000368999FGFR2chr10123243212-TACC2chr10123996910+0.0014822880.9985177
ENST00000346997ENST00000369004FGFR2chr10123243212-TACC2chr10123996910+0.0012731790.9987268
ENST00000346997ENST00000260733FGFR2chr10123243212-TACC2chr10123996910+0.0013212680.99867874
ENST00000369056ENST00000369005FGFR2chr10123243212-TACC2chr10123996910+0.0013978990.9986021
ENST00000369056ENST00000513429FGFR2chr10123243212-TACC2chr10123996910+0.0013510260.99864894
ENST00000369056ENST00000515273FGFR2chr10123243212-TACC2chr10123996910+0.0018627110.99813724
ENST00000369056ENST00000515603FGFR2chr10123243212-TACC2chr10123996910+0.0018439920.998156
ENST00000369056ENST00000453444FGFR2chr10123243212-TACC2chr10123996910+0.0018627110.99813724
ENST00000369056ENST00000358010FGFR2chr10123243212-TACC2chr10123996910+0.001404110.9985959
ENST00000369056ENST00000334433FGFR2chr10123243212-TACC2chr10123996910+0.001404110.9985959
ENST00000369056ENST00000369001FGFR2chr10123243212-TACC2chr10123996910+0.0013978990.9986021
ENST00000369056ENST00000369000FGFR2chr10123243212-TACC2chr10123996910+0.0013683540.99863166
ENST00000369056ENST00000360561FGFR2chr10123243212-TACC2chr10123996910+0.0013510260.99864894
ENST00000369056ENST00000368999FGFR2chr10123243212-TACC2chr10123996910+0.0015740390.99842596
ENST00000369056ENST00000369004FGFR2chr10123243212-TACC2chr10123996910+0.0013510260.99864894
ENST00000369056ENST00000260733FGFR2chr10123243212-TACC2chr10123996910+0.0013971430.9986029
ENST00000369061ENST00000369005FGFR2chr10123243211-TACC2chr10123996909+0.0018957520.9981042
ENST00000369061ENST00000513429FGFR2chr10123243211-TACC2chr10123996909+0.0018264590.9981736
ENST00000369061ENST00000515273FGFR2chr10123243211-TACC2chr10123996909+0.0026172630.9973827
ENST00000369061ENST00000515603FGFR2chr10123243211-TACC2chr10123996909+0.002575950.9974241
ENST00000369061ENST00000453444FGFR2chr10123243211-TACC2chr10123996909+0.0026172630.9973827
ENST00000369061ENST00000358010FGFR2chr10123243211-TACC2chr10123996909+0.0019088510.99809116
ENST00000369061ENST00000334433FGFR2chr10123243211-TACC2chr10123996909+0.0019088510.99809116
ENST00000369061ENST00000369001FGFR2chr10123243211-TACC2chr10123996909+0.0018957520.9981042
ENST00000369061ENST00000369000FGFR2chr10123243211-TACC2chr10123996909+0.0018550010.998145
ENST00000369061ENST00000360561FGFR2chr10123243211-TACC2chr10123996909+0.0018264590.9981736
ENST00000369061ENST00000368999FGFR2chr10123243211-TACC2chr10123996909+0.0021426780.9978573
ENST00000369061ENST00000369004FGFR2chr10123243211-TACC2chr10123996909+0.0018264590.9981736
ENST00000369061ENST00000260733FGFR2chr10123243211-TACC2chr10123996909+0.0018964620.9981035
ENST00000346997ENST00000369005FGFR2chr10123243211-TACC2chr10123996909+0.0013218690.99867815
ENST00000346997ENST00000513429FGFR2chr10123243211-TACC2chr10123996909+0.0012731790.9987268
ENST00000346997ENST00000515273FGFR2chr10123243211-TACC2chr10123996909+0.0017400990.99825996
ENST00000346997ENST00000515603FGFR2chr10123243211-TACC2chr10123996909+0.0017227880.9982772
ENST00000346997ENST00000453444FGFR2chr10123243211-TACC2chr10123996909+0.0017400990.99825996
ENST00000346997ENST00000358010FGFR2chr10123243211-TACC2chr10123996909+0.0013270060.99867296
ENST00000346997ENST00000334433FGFR2chr10123243211-TACC2chr10123996909+0.0013270060.99867296
ENST00000346997ENST00000369001FGFR2chr10123243211-TACC2chr10123996909+0.0013218690.99867815
ENST00000346997ENST00000369000FGFR2chr10123243211-TACC2chr10123996909+0.0012924250.99870753
ENST00000346997ENST00000360561FGFR2chr10123243211-TACC2chr10123996909+0.0012731790.9987268
ENST00000346997ENST00000368999FGFR2chr10123243211-TACC2chr10123996909+0.0014822880.9985177
ENST00000346997ENST00000369004FGFR2chr10123243211-TACC2chr10123996909+0.0012731790.9987268
ENST00000346997ENST00000260733FGFR2chr10123243211-TACC2chr10123996909+0.0013212680.99867874
ENST00000369056ENST00000369005FGFR2chr10123243211-TACC2chr10123996909+0.0013978990.9986021
ENST00000369056ENST00000513429FGFR2chr10123243211-TACC2chr10123996909+0.0013510260.99864894
ENST00000369056ENST00000515273FGFR2chr10123243211-TACC2chr10123996909+0.0018627110.99813724
ENST00000369056ENST00000515603FGFR2chr10123243211-TACC2chr10123996909+0.0018439920.998156
ENST00000369056ENST00000453444FGFR2chr10123243211-TACC2chr10123996909+0.0018627110.99813724
ENST00000369056ENST00000358010FGFR2chr10123243211-TACC2chr10123996909+0.001404110.9985959
ENST00000369056ENST00000334433FGFR2chr10123243211-TACC2chr10123996909+0.001404110.9985959
ENST00000369056ENST00000369001FGFR2chr10123243211-TACC2chr10123996909+0.0013978990.9986021
ENST00000369056ENST00000369000FGFR2chr10123243211-TACC2chr10123996909+0.0013683540.99863166
ENST00000369056ENST00000360561FGFR2chr10123243211-TACC2chr10123996909+0.0013510260.99864894
ENST00000369056ENST00000368999FGFR2chr10123243211-TACC2chr10123996909+0.0015740390.99842596
ENST00000369056ENST00000369004FGFR2chr10123243211-TACC2chr10123996909+0.0013510260.99864894
ENST00000369056ENST00000260733FGFR2chr10123243211-TACC2chr10123996909+0.0013971430.9986029

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for FGFR2-TACC2

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
FGFR2chr10123243211TACC2chr101239969092115689EDLDRILTLTTNEREAAHPTDVSISK
FGFR2chr10123243211TACC2chr101239969092307765EDLDRILTLTTNEREAAHPTDVSISK
FGFR2chr10123243211TACC2chr101239969092328768EDLDRILTLTTNEREAAHPTDVSISK
FGFR2chr10123243212TACC2chr101239969102115689EDLDRILTLTTNEREAAHPTDVSISK
FGFR2chr10123243212TACC2chr101239969102307765EDLDRILTLTTNEREAAHPTDVSISK
FGFR2chr10123243212TACC2chr101239969102328768EDLDRILTLTTNEREAAHPTDVSISK

Top

Potential FusionNeoAntigen Information of FGFR2-TACC2 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
FGFR2-TACC2_123243211_123996909.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
FGFR2-TACC2chr10123243211chr101239969092307HLA-B45:01NEREAAHPT0.96490.57061120
FGFR2-TACC2chr10123243211chr101239969092307HLA-B50:01NEREAAHPT0.30670.59291120
FGFR2-TACC2chr10123243211chr101239969092307HLA-A74:11RILTLTTNER0.9870.5872414
FGFR2-TACC2chr10123243211chr101239969092307HLA-A74:03RILTLTTNER0.9870.5872414
FGFR2-TACC2chr10123243211chr101239969092307HLA-A74:09RILTLTTNER0.9870.5872414
FGFR2-TACC2chr10123243211chr101239969092307HLA-A31:02RILTLTTNER0.96550.5409414
FGFR2-TACC2chr10123243211chr101239969092307HLA-B50:04NEREAAHPT0.30670.59291120
FGFR2-TACC2chr10123243211chr101239969092307HLA-B50:05NEREAAHPT0.30670.59291120
FGFR2-TACC2chr10123243211chr101239969092307HLA-A74:01RILTLTTNER0.9870.5872414

Top

Potential FusionNeoAntigen Information of FGFR2-TACC2 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
FGFR2-TACC2_123243211_123996909.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0324ILTLTTNEREAAHPT520
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0324RILTLTTNEREAAHP419
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0403DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0403LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0409DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0411DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0411LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0411DLDRILTLTTNEREA116
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0417DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0417LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0424DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0427LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0427DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0439DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0439LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0441DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0441LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0446DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0446LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0449DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0449LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0450DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0450LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0451DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0451LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0452DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0452LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0459LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0459DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0460DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0460LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0467DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0467LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0471DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0471LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0478DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0485DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0485LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0487DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0488DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0488LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0491DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0491LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-0491DLDRILTLTTNEREA116
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1204LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1204DLDRILTLTTNEREA116
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1204DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1209LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1209DLDRILTLTTNEREA116
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1209DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1406LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1410DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1410LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1420LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1429LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1429DLDRILTLTTNEREA116
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1429DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1452LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1452DLDRILTLTTNEREA116
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1452DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB1-1483LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB5-0102LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB5-0106LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB5-0106DLDRILTLTTNEREA116
FGFR2-TACC2chr10123243211chr101239969092307DRB5-0106DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB5-0108NLDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB5-0202LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB5-0202DLDRILTLTTNEREA116
FGFR2-TACC2chr10123243211chr101239969092307DRB5-0202DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB5-0204LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB5-0204DLDRILTLTTNEREA116
FGFR2-TACC2chr10123243211chr101239969092307DRB5-0205LDRILTLTTNEREAA217
FGFR2-TACC2chr10123243211chr101239969092307DRB5-0205DLDRILTLTTNEREA116
FGFR2-TACC2chr10123243211chr101239969092307DRB5-0205DRILTLTTNEREAAH318
FGFR2-TACC2chr10123243211chr101239969092307DRB5-0205EDLDRILTLTTNERE015

Top

Fusion breakpoint peptide structures of FGFR2-TACC2

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
5719LTLTTNEREAAHPTFGFR2TACC2chr10123243211chr101239969092307

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of FGFR2-TACC2

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN5719LTLTTNEREAAHPT-7.15543-7.26883
HLA-B14:023BVN5719LTLTTNEREAAHPT-4.77435-5.80965
HLA-B52:013W395719LTLTTNEREAAHPT-6.80875-6.92215
HLA-B52:013W395719LTLTTNEREAAHPT-4.20386-5.23916
HLA-A11:014UQ25719LTLTTNEREAAHPT-7.5194-8.5547
HLA-A11:014UQ25719LTLTTNEREAAHPT-6.9601-7.0735
HLA-A24:025HGA5719LTLTTNEREAAHPT-7.52403-7.63743
HLA-A24:025HGA5719LTLTTNEREAAHPT-5.82433-6.85963
HLA-B27:056PYJ5719LTLTTNEREAAHPT-3.28285-4.31815
HLA-B44:053DX85719LTLTTNEREAAHPT-5.91172-6.94702
HLA-B44:053DX85719LTLTTNEREAAHPT-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of FGFR2-TACC2

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
FGFR2-TACC2chr10123243211chr101239969091120NEREAAHPTAATGAGAGAGAGGCTGCTCACCCAACA
FGFR2-TACC2chr10123243211chr10123996909414RILTLTTNERCGAATTCTCACTCTCACAACCAATGAGAGA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
FGFR2-TACC2chr10123243211chr10123996909015EDLDRILTLTTNEREGAAGACTTGGATCGAATTCTCACTCTCACAACCAATGAGAGAGAG
FGFR2-TACC2chr10123243211chr10123996909116DLDRILTLTTNEREAGACTTGGATCGAATTCTCACTCTCACAACCAATGAGAGAGAGGCT
FGFR2-TACC2chr10123243211chr10123996909217LDRILTLTTNEREAATTGGATCGAATTCTCACTCTCACAACCAATGAGAGAGAGGCTGCT
FGFR2-TACC2chr10123243211chr10123996909318DRILTLTTNEREAAHGATCGAATTCTCACTCTCACAACCAATGAGAGAGAGGCTGCTCAC
FGFR2-TACC2chr10123243211chr10123996909419RILTLTTNEREAAHPCGAATTCTCACTCTCACAACCAATGAGAGAGAGGCTGCTCACCCA
FGFR2-TACC2chr10123243211chr10123996909520ILTLTTNEREAAHPTATTCTCACTCTCACAACCAATGAGAGAGAGGCTGCTCACCCAACA

Top

Information of the samples that have these potential fusion neoantigens of FGFR2-TACC2

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADFGFR2-TACC2chr10123243211ENST00000346997chr10123996909ENST00000260733TCGA-BR-8080

Top

Potential target of CAR-T therapy development for FGFR2-TACC2

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneFGFR2chr10:123243211chr10:123996909ENST00000346997-1617378_398765820.0TransmembraneHelical
HgeneFGFR2chr10:123243211chr10:123996909ENST00000351936-1718378_398765786.0TransmembraneHelical
HgeneFGFR2chr10:123243211chr10:123996909ENST00000356226-1516378_398650705.0TransmembraneHelical
HgeneFGFR2chr10:123243211chr10:123996909ENST00000357555-1617378_398678708.0TransmembraneHelical
HgeneFGFR2chr10:123243211chr10:123996909ENST00000358487-1718378_398767822.0TransmembraneHelical
HgeneFGFR2chr10:123243211chr10:123996909ENST00000360144-1617378_398679681.0TransmembraneHelical
HgeneFGFR2chr10:123243211chr10:123996909ENST00000369056-1617378_398768770.0TransmembraneHelical
HgeneFGFR2chr10:123243211chr10:123996909ENST00000369060-1516378_398651706.0TransmembraneHelical
HgeneFGFR2chr10:123243211chr10:123996909ENST00000369061-1415378_398655710.0TransmembraneHelical
HgeneFGFR2chr10:123243211chr10:123996909ENST00000457416-1718378_398768823.0TransmembraneHelical
HgeneFGFR2chr10:123243212chr10:123996910ENST00000346997-1617378_398765820.0TransmembraneHelical
HgeneFGFR2chr10:123243212chr10:123996910ENST00000351936-1718378_398765786.0TransmembraneHelical
HgeneFGFR2chr10:123243212chr10:123996910ENST00000356226-1516378_398650705.0TransmembraneHelical
HgeneFGFR2chr10:123243212chr10:123996910ENST00000357555-1617378_398678708.0TransmembraneHelical
HgeneFGFR2chr10:123243212chr10:123996910ENST00000358487-1718378_398767822.0TransmembraneHelical
HgeneFGFR2chr10:123243212chr10:123996910ENST00000360144-1617378_398679681.0TransmembraneHelical
HgeneFGFR2chr10:123243212chr10:123996910ENST00000369056-1617378_398768770.0TransmembraneHelical
HgeneFGFR2chr10:123243212chr10:123996910ENST00000369060-1516378_398651706.0TransmembraneHelical
HgeneFGFR2chr10:123243212chr10:123996910ENST00000369061-1415378_398655710.0TransmembraneHelical
HgeneFGFR2chr10:123243212chr10:123996910ENST00000457416-1718378_398768823.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to FGFR2-TACC2

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to FGFR2-TACC2

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneFGFR2C2931196Craniofacial dysostosis type 123CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneFGFR2C0220658Pfeiffer Syndrome21CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneFGFR2C0001193Apert syndrome19CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
HgeneFGFR2C0795998JACKSON-WEISS SYNDROME10CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
HgeneFGFR2C0175699Saethre-Chotzen Syndrome8CTD_human;GENOMICS_ENGLAND;ORPHANET
HgeneFGFR2C1852406Cutis Gyrata Syndrome of Beare And Stevenson8CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
HgeneFGFR2C2936791Antley-Bixler Syndrome, Autosomal Dominant7CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
HgeneFGFR2C1510455Acrocephalosyndactylia6CTD_human;ORPHANET
HgeneFGFR2C0265269Lacrimoauriculodentodigital syndrome5CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
HgeneFGFR2C0010278Craniosynostosis4CTD_human;GENOMICS_ENGLAND
HgeneFGFR2C1863389Apert-Crouzon Disease4CTD_human
HgeneFGFR2C1865070SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION4CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
HgeneFGFR2C0006142Malignant neoplasm of breast3CTD_human;UNIPROT
HgeneFGFR2C0030044Acrocephaly3CTD_human
HgeneFGFR2C0036341Schizophrenia3PSYGENET
HgeneFGFR2C0221356Brachycephaly3CTD_human
HgeneFGFR2C0265534Scaphycephaly3CTD_human
HgeneFGFR2C0265535Trigonocephaly3CTD_human
HgeneFGFR2C0376634Craniofacial Abnormalities3CTD_human
HgeneFGFR2C0678222Breast Carcinoma3CTD_human
HgeneFGFR2C1257931Mammary Neoplasms, Human3CTD_human
HgeneFGFR2C1458155Mammary Neoplasms3CTD_human
HgeneFGFR2C1833340Synostotic Posterior Plagiocephaly3CTD_human
HgeneFGFR2C1860819Metopic synostosis3CTD_human
HgeneFGFR2C2931150Synostotic Anterior Plagiocephaly3CTD_human
HgeneFGFR2C3281247BENT BONE DYSPLASIA SYNDROME3CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
HgeneFGFR2C4551902Craniosynostosis, Type 13CTD_human
HgeneFGFR2C4704874Mammary Carcinoma, Human3CTD_human
HgeneFGFR2C0008925Cleft Palate2CTD_human
HgeneFGFR2C0011570Mental Depression2PSYGENET
HgeneFGFR2C0011581Depressive disorder2PSYGENET
HgeneFGFR2C0024623Malignant neoplasm of stomach2CGI;CTD_human
HgeneFGFR2C0038356Stomach Neoplasms2CGI;CTD_human
HgeneFGFR2C1708349Hereditary Diffuse Gastric Cancer2CTD_human
HgeneFGFR2C1837218Cleft palate, isolated2CTD_human
HgeneFGFR2C0000772Multiple congenital anomalies1CTD_human
HgeneFGFR2C0003090Ankylosis1CTD_human
HgeneFGFR2C0005586Bipolar Disorder1PSYGENET
HgeneFGFR2C0008924Cleft upper lip1CTD_human
HgeneFGFR2C0010273Craniofacial Dysostosis1CTD_human
HgeneFGFR2C0011757Developmental Coordination Disorder1CTD_human
HgeneFGFR2C0014170Endometrial Neoplasms1CTD_human
HgeneFGFR2C0018553Hamartoma Syndrome, Multiple1CTD_human
HgeneFGFR2C0020796Profound Mental Retardation1CTD_human
HgeneFGFR2C0023890Liver Cirrhosis1CTD_human
HgeneFGFR2C0024121Lung Neoplasms1CTD_human
HgeneFGFR2C0025363Mental Retardation, Psychosocial1CTD_human
HgeneFGFR2C0026613Motor Skills Disorders1CTD_human
HgeneFGFR2C0033975Psychotic Disorders1PSYGENET
HgeneFGFR2C0037268Skin Abnormalities1CTD_human
HgeneFGFR2C0037274Dermatologic disorders1CTD_human
HgeneFGFR2C0038219Status Dysraphicus1CTD_human
HgeneFGFR2C0040427Tooth Abnormalities1CTD_human
HgeneFGFR2C0080178Spina Bifida1CTD_human
HgeneFGFR2C0152423Congenital small ears1GENOMICS_ENGLAND
HgeneFGFR2C0206698Cholangiocarcinoma1CTD_human
HgeneFGFR2C0206762Limb Deformities, Congenital1CTD_human
HgeneFGFR2C0239946Fibrosis, Liver1CTD_human
HgeneFGFR2C0242379Malignant neoplasm of lung1CTD_human
HgeneFGFR2C0265326Bannayan-Riley-Ruvalcaba Syndrome1CTD_human
HgeneFGFR2C0266508Rachischisis1CTD_human
HgeneFGFR2C0345905Intrahepatic Cholangiocarcinoma1CTD_human
HgeneFGFR2C0349204Nonorganic psychosis1PSYGENET
HgeneFGFR2C0391826Lhermitte-Duclos disease1CTD_human
HgeneFGFR2C0476089Endometrial Carcinoma1CGI;CTD_human
HgeneFGFR2C0524730Odontome1CTD_human
HgeneFGFR2C0699791Stomach Carcinoma1CGI;GENOMICS_ENGLAND
HgeneFGFR2C0917816Mental deficiency1CTD_human
HgeneFGFR2C1450010Plagiocephaly, Nonsynostotic1CTD_human
HgeneFGFR2C1860042Antley-Bixler Syndrome with Disordered Steroidogenesis1CTD_human
HgeneFGFR2C1867564SCAPHOCEPHALY AND AXENFELD-RIEGER ANOMALY1GENOMICS_ENGLAND
HgeneFGFR2C1959582PTEN Hamartoma Tumor Syndrome1CTD_human
HgeneFGFR2C2350233Antley-Bixler Syndrome Phenotype1CTD_human
HgeneFGFR2C3267076Familial scaphocephaly syndrome1GENOMICS_ENGLAND
HgeneFGFR2C3714756Intellectual Disability1CTD_human
HgeneFGFR2C3805278Extrahepatic Cholangiocarcinoma1CTD_human